In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page

New EMA pilot project helps to facilitate validation of initial marketing authorisation applications

by In2Pharma | Mar 15, 2019 | News

Europe EMA launched a five-month pilot study to increase the correct submissions of initial marketing authorisations applications (MAAs). The pilot is a result of the 2016 EMA survey that showed validation issues occur in 90% of all initial applications. The pilot...

Recent Posts

  • Introduction to FAMHP portal – manufacturing inspections
  • RD export 19/01/2023 – mandatory application for export
  • Fiscal importation of medicines from 3rd countries
  • NARCOTIC/PSYCHOTROPIC LEGISLATION: important clarifications concerning the narcotic order forms
  • Negative formulations no longer allowed on packaging of medicinal products for human use

Follow Us

  • Facebook
  • LinkedIn
Privacy Policy | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com | Terloonststraat 22, 1910 Kampenhout, België